04/25/2024
7:39 PM | Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
04/11/2024
7:42 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:41 AM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
01/31/2024
8:34 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:37 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:37 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:38 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:39 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:41 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:42 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
4:28 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:10 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:51 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/13/2023
1:44 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:30 PM | Leap Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Hard Truth About Investing For Retirement (Ad) Here’s the cold, hard truth about investing:
The more capital you have, the more risk averse you can afford to be.
But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive.
In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
4:15 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
4:26 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
06/14/2023
3:31 PM | Leap Therapeutics (Filer)
| Form 424B3 | |
05/25/2023
4:18 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:06 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
5:50 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
